Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 20.19B | 23.83B | 17.46B | 20.78B | 23.60B | 18.52B |
Gross Profit | 8.07B | 9.35B | 5.24B | 7.39B | 8.97B | 6.47B |
EBITDA | 4.97B | 5.86B | 2.11B | 4.31B | 5.97B | 3.59B |
Net Income | 2.70B | 3.45B | 622.00M | 2.61B | 3.80B | 2.04B |
Balance Sheet | ||||||
Total Assets | 35.11B | 39.86B | 34.77B | 32.69B | 32.99B | 25.58B |
Cash, Cash Equivalents and Short-Term Investments | 11.28B | 12.19B | 14.25B | 12.81B | 11.82B | 6.66B |
Total Debt | 4.85B | 5.88B | 5.66B | 4.18B | 5.19B | 6.46B |
Total Liabilities | 8.97B | 11.94B | 10.10B | 8.45B | 11.20B | 10.17B |
Stockholders Equity | 26.14B | 27.91B | 24.67B | 24.24B | 21.79B | 15.41B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -1.66B | 397.00M | 2.43B | 3.89B | 19.00M |
Operating Cash Flow | 0.00 | 1.80B | 2.31B | 3.35B | 4.81B | 1.42B |
Investing Cash Flow | 0.00 | -3.58B | -2.20B | -849.00M | -562.00M | -1.50B |
Financing Cash Flow | 0.00 | -514.00M | 879.00M | -1.58B | 947.00M | 2.97B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥38.86B | 8.71 | 3.81% | 7.88% | 39.72% | ||
77 Outperform | ¥29.19B | 8.45 | 1.73% | 36.47% | 454.90% | ||
75 Outperform | ¥29.66B | 8.99 | 3.37% | 3.61% | -14.91% | ||
73 Outperform | ¥29.01B | 10.96 | 3.62% | -0.38% | 6.16% | ||
69 Neutral | ¥203.07B | 4.00 | 0.38% | -48.30% | ― | ||
63 Neutral | $34.04B | 6.14 | -11.52% | 1.82% | 5.53% | -18.79% | |
58 Neutral | ¥14.88B | ― | 4.12% | -6.97% | 45.07% |